2023-03-14T21:37:58-05:00 2022-06-30 430765316 RUBINBROWN LLP 7676 FORSYTH BLVD SUITE 2100 SAINT LOUIS MO 63105 990 2021-07-01 131632524 AMERICAN LUNG ASSOCIATION AMER 2177875864 55 W WACKER DRIVE CHICAGO IL 60601 LAURA SCOTT CFO 2177875864 2023-03-10 1 LAURA SCOTT 999009999 KIMBERLY A RYAN P00829977 3142903300 0 AAL1 IAL1 2021 2023-04-26 12:10:37Z HAROLD WIMMER 55 W WACKER DRIVE CHICAGO IL 60601 146789377 0 X WWW.LUNG.ORG X 1918 ME THE MISSION OF THE ALA IS TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. 19 19 647 80222 0 0 83540236 112291164 7910149 2513033 6732235 9862711 1392606 4726028 99575226 129392936 12606840 13235010 0 0 41720667 41926003 414866 446755 11432174 43990188 46318937 98732561 101926705 842665 27466231 232813823 215049116 64375082 49385591 168438741 165663525 X THE AMERICAN LUNG ASSOCIATION'S MISSION IS TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. WE DO THIS THROUGH EDUCATION, ADVOCACY, AND RESEARCH. 0 0 48822218 2288870 LUNG CANCER, ASTHMA, LUNG DISEASE AND TOBACCO CONTROL: LUNG DISEASE, INCLUDING COPD, IS A LEADING CAUSE OF DEATH IN AMERICA AND LUNG CANCER IS THE LEADING CAUSE OF CANCER DEATH. THE COVID-19 PANDEMIC, IN ITS THIRD YEAR, CONTINUES TO BE A PRIORITY FOR THE COUNTRY AND FOR THE AMERICAN LUNG ASSOCIATION. THE LUNG ASSOCIATION WORKS EVERY DAY ACROSS THE U.S. TO RAISE AWARENESS FOR THE NEED TO PRIORITIZE LUNG DISEASE PREVENTION AND TREATMENT, PROTECT OUR AIR, REDUCE TOBACCO USE, PROVIDE SUPPORT FOR PEOPLE LIVING WITH LUNG DISEASE AND THEIR CAREGIVERS, AND RAISE FUNDS FOR RESEARCH TO BENEFIT EVERYONE'S LUNGS. AS THE COVID-19 PANDEMIC EVOLVED IN THIS COUNTRY, OUR RESPONSE ADAPTED AS WELL. OUR COVID-19 ACTION INITIATIVE CONTINUED TO SHOW REAL IMPACT AS THE CATALYST FOR NEW COVID-19 ADVOCACY, OUTREACH AND RESEARCH GRANTS, INCLUDING THE COVID-19 AND RESPIRATORY VIRUS RESEARCH AWARD WHICH PROVIDES $100,000 OF FUNDING A YEAR FOR TWO YEARS. AS A FOUNDING PARTNER OF THE WHITE HOUSE VACCINATION TASK FORCE, WE INVITED AMERICANS TO BECOME AN AMERICAN LUNG ASSOCIATION VACCINE AMBASSADOR BY DOWNLOADING OUR VACCINE TOOLKIT AND USING ITS INFORMATION TO EDUCATE THEIR FAMILY AND FRIENDS ABOUT THE IMPORTANCE OF LIFESAVING COVID-19 VACCINATIONS. OUR BETTER FOR IT TOOLKITS ALSO HELPED POPULATIONS THAT ARE HISTORICALLY HESITANT ABOUT VACCINATIONS MAKE INFORMED DECISIONS ABOUT COVID-19 VACCINATION. IN SEPTEMBER 2021, OUR COVID-19 RELIEF FREEDOM FROM SMOKING (FFS) PLUS PROGRAM PROVIDED A ONE-YEAR FREE MEMBERSHIP TO FREEDOM FROM SMOKING PLUS CESSATION PROGRAM TO HUNDREDS WHO QUIT SMOKING DURING THE PANDEMIC. TO REDUCE MISINFORMATION AND CONFUSION ABOUT MASK USE DURING THE PANDEMIC, WE PRODUCED A SERIES OF COMMUNICATIONS EXPLAINING THE TYPES OF MASKS AND THEIR PROPER USE, INCLUDING AN INFOGRAPHIC, WIDELY SHARED ON SOCIAL MEDIA.IN OCTOBER 2021, WE LAUNCHED A NEW ONLINE COMMUNITY CALLED LIVING WITH LONG COVID. THIS COMMUNITY ALLOWS THOSE FACING LONG COVID AND THEIR LOVED ONES TO CONNECT AND RECEIVE PEER-TO-PEER SUPPORT. IT JOINS OUR TEN OTHER ONLINE SUPPORT COMMUNITIES. ADDITIONALLY, OUR BETTER BREATHERS CLUBS BEGAN ACCEPTING THOSE WITH LONG COVID SYMPTOMS INTO THEIR ONLINE AND IN-PERSON SUPPORT GROUPS.TO INCREASE ACCESS TO IMPORTANT HEALTH EDUCATION, WE EXPANDED OUR WEBSITE TO THE TEN MOST-USED LANGUAGES IN THE U.S. TO EDUCATE MORE PEOPLE ABOUT COVID-19, LUNG CANCER AND OTHER LUNG DISEASES. LUNG.ORG IS NOW AVAILABLE IN ENGLISH, SPANISH, ARABIC, CHINESE (SIMPLIFIED MANDARIN), FILIPINO, FRENCH, GERMAN, KOREAN, RUSSIAN AND VIETNAMESE. AND THROUGHOUT THE YEAR, OUR GROWING AND ENGAGED SOCIAL AUDIENCE RELIED ON US TO GIVE THEM INFORMATION THEY COULD TRUST ACROSS ALL OUR SOCIAL CHANNELS. IN ADDITION TO COVID-19, WE CONTINUED TO FOCUS ON ALL LUNG DISEASES, INCLUDING LUNG CANCER. WE CONTINUED OUR FOCUS ON REDUCING LUNG CANCER THROUGH OUR ONGOING LUNG FORCE INITIATIVE WHICH RAISES AWARENESS, LUNG CANCER RESEARCH FUNDING, AND PROVIDES EDUCATION AND SUPPORT TO LUNG CANCER PATIENTS AND CAREGIVERS. OUR "SAVED BY THE SCAN" CAMPAIGN RAISED AWARENESS ABOUT LIFESAVING LUNG CANCER SCREENING BY GENERATING OVER 140,000 QUIZ COMPLETIONS TO HELP PEOPLE LEARN IF THEY SHOULD BE SCANNED FOR LUNG CANCER. IN NOVEMBER 2021, WE OBSERVED LUNG CANCER AWARENESS MONTH BY SHARING NEW LUNG CANCER RESOURCES, INSPIRING PATIENT STORIES AND LIFESAVING LUNG CANCER SCREENING INFORMATION. WE ALSO RELEASED OUR LUNG HEALTH BAROMETER, WHICH SURVEYED 4,000 WOMEN AND MEN ABOUT THEIR UNDERSTANDING OF LUNG CANCER. IT FOUND THAT LUNG CANCER AWARENESS CONTINUES TO IMPROVE BUT MORE WORK STILL NEEDS TO BE DONE. IN NOVEMBER WE ALSO RELEASED OUR ANNUAL "STATE OF LUNG CANCER" REPORT, WHICH EXAMINES KEY LUNG CANCER INDICATORS THROUGHOUT EACH STATE.RADON EXPOSURE IS THE SECOND LEADING CAUSE OF LUNG CANCER. DURING JANUARY, RADON ACTION MONTH, AND THROUGHOUT THE YEAR, WE ENCOURAGE EVERYONE TO TEST THEIR HOMES FOR RADON AND SEEK RADON MITIGATION IF NECESSARY. THE LUNG ASSOCIATION LED THE EFFORT TO CREATE THE NEW FIVE-YEAR NATIONAL RADON ACTION PLAN WITH THE GOAL OF REDUCING HEALTH INEQUITIES TO PROTECT ALL AMERICANS FROM RADON EXPOSURE.IN MARCH, WE HELD OUR SEVENTH ANNUAL LUNG FORCE ADVOCACY DAY. LUNG FORCE HEROES - THOSE PERSONALLY AFFECTED BY LUNG CANCER - FROM ACROSS THE COUNTRY CALLED THEIR MEMBERS OF CONGRESS AND ASKED THEM TO SUPPORT $49 BILLION IN RESEARCH FUNDING FOR THE NATIONAL INSTITUTES OF HEALTH AND $11 BILLION IN FUNDING FOR THE CDC. THEY ALSO URGED THEM TO MAKE QUALITY HEALTHCARE MORE AFFORDABLE FOR MILLIONS OF AMERICANS BY MAKING THE EXPANDED PREMIUM TAX CREDITS PERMANENT. ASTHMA MAKES BREATHING DIFFICULT FOR MILLIONS OF AMERICANS, INCLUDING 5.5 MILLION CHILDREN. THIS YEAR, WE PUBLISHED OUR NEW INDOOR AIR QUALITY IN SCHOOLS GUIDE AND UPDATED OUR OTHER ASTHMA RESOURCES INCLUDING OUR ASTHMA FRIENDLY SCHOOLS ONLINE MODULE, KICKIN' ASTHMA, OPEN AIRWAYS FOR SCHOOLS AND MORE. WE TEAMED UP WITH OTHER HEALTH ORGANIZATIONS TO CREATE "LITTLE AIRWAYS, BIG VOICES," A PROGRAM TO BRING THE VOICE OF FAMILIES IMPACTED BY ASTHMA IN CHILDHOOD TO THE FOREFRONT OF DRUG DEVELOPMENT AND RESEARCH. WE LAUNCHED OUR NEW FEND OFF FLU EDUCATIONAL CAMPAIGN TO INCREASE INFLUENZA KNOWLEDGE AND VACCINATION RATES. OUR LUNGCAST PODCAST SERIES, PRESENTED IN PARTNERSHIP WITH HCPLIVE, CONTINUED TO PROVIDE HEALTHCARE PROFESSIONALS WITH THE LATEST SCIENCE IN COVID-19 AND OTHER LUNG TOPICS; INCLUDED SESSIONS ON COPD, LUNG CANCER SCREENING, SLEEP APNEA AND MORE. EVERY YEAR IN THE U.S., MORE THAN 480,000 PEOPLE DIE FROM TOBACCO USE AND EXPOSURE TO SECONDHAND SMOKE, MAKING IT THE LEADING CAUSE OF PREVENTABLE DEATH IN THIS COUNTRY. TRAGICALLY, EACH DAY THOUSANDS OF KIDS STILL PICK UP A TOBACCO PRODUCT FOR THE FIRST TIME. E-CIGARETTES ARE ALSO TOBACCO PRODUCTS AND YOUTH VAPING HAS BECOME AN EPIDEMIC THAT THREATENS TO ADDICT ANOTHER GENERATION TO NICOTINE. THAT'S WHY CREATING A TOBACCO-FREE FUTURE FOR AMERICA IS A CORE PART OF OUR MISSION. THE AMERICAN LUNG ASSOCIATION HAS COMMITTED $2 MILLION TOWARD RESEARCH TO UNDERSTAND THE ALARMING EFFECTS OF VAPING ON KIDS AND FIND A SOLUTION TO VAPING RELATED LUNG INJURY.AS PART OF OUR EDUCATION AND AWARENESS EFFORTS ON YOUTH VAPING, WE CONTINUED PROMOTING OUR "GET YOUR HEAD OUT OF THE CLOUD" CAMPAIGN, PRODUCED IN COLLABORATION WITH THE AD COUNCIL. THIS CAMPAIGN REACHED 160,000 AMERICAN PARENTS WITH FACTS AND GUIDANCE ON HOW TO TALK ABOUT VAPING WITH THEIR KIDS. IN AUGUST 2021, WE ANNOUNCED THE VAPE-FREE SCHOOLS SCHOLARSHIP FUND, A NEW EFFORT TO FUND SCHOOLS' IMPLEMENTATION OF OUR VAPE-FREE SCHOOLS INITIATIVE, SO THAT MORE KIDS CAN ACCESS CESSATION, SUPPORT AND EDUCATION. THE SCHOLARSHIP DRIVE SOUGHT TO RAISE FUNDS TO GIVE SCHOOLS ACROSS THE COUNTRY ACCESS TO ONLINE TRAINING AND RESOURCES TO HELP STUDENTS QUIT VAPING. THE VAPE-FREE SCHOOLS INITIATIVE INCLUDES NOT ON TOBACCO (N-O-T), OUR VOLUNTARY QUIT SMOKING PROGRAM FOR TEENS, AND INDEPTH, AN ALTERNATIVE FOR STUDENTS WHO FACE SUSPENSION FOR VIOLATION OF SCHOOL TOBACCO, VAPING OR NICOTINE USE POLICIES. WE ALSO LAUNCHED NOT FOR ME, A WEB-BASED PROGRAM THAT GIVES STUDENTS THE TOOLS TO QUIT SMOKING OR VAPING. IT TEACHES TEENS ABOUT THE IMPORTANCE OF PHYSICAL ACTIVITY, NUTRITION, ENHANCING THEIR SENSE OF SELF-CONTROL AND MORE.WE ENCOURAGED SMOKERS TO KEEP THEIR NEW YEAR'S RESOLUTION TO QUIT, AND START A TOBACCO-FREE LIFE IN 2022, PROVIDING TOOLS AND SUPPORT TO HELP, INCLUDING OUR LUNG HELPLINE AND TOBACCO QUITLINE (1-800-LUNGUSA), FREEDOM FROM SMOKING PROGRAM AND SUPPORT GROUPS.OUR 20TH ANNUAL "STATE OF TOBACCO CONTROL" REPORT, LAUNCHED IN JANUARY, CELEBRATED THE PROGRESS WE'VE MADE OVER THE LAST TWO DECADES TO END TOBACCO USE BUT FOUND THAT PRODUCTS LIKE E-CIGARETTES AND OTHER FLAVORED TOBACCO PRODUCTS CREATE CONCERN FOR LOSING ANOTHER GENERATION TO NICOTINE ADDICTION. THE REPORT ALSO CALLED ON THE BIDEN ADMINISTRATION TO REMOVE MENTHOL CIGARETTES AND FLAVORED CIGARS FROM THE MARKETPLACE. JUST FOUR MONTHS AFTER THE RELEASE OF OUR REPORT, THE FDA DID JUST THAT AND PROPOSED REMOVING THESE HARMFUL AND HIGHLY ADDICTIVE PRODUCTS FROM THE MARKET. 20734419 13235010 972065 RESEARCH:FEW THINGS PROMISE TO IMPROVE PATIENTS' LIVES MORE THAN MEDICAL RESEARCH. FOR NEARLY 120 YEARS, THE AMERICAN LUNG ASSOCIATION HAS FOCUSED ON DRIVING EXCELLENCE AND INNOVATION THROUGH RESEARCH. WHEN WE LAUNCHED OUR COVID-19 ACTION INITIATIVE IN 2019, WE MADE RESEARCH OF CORONAVIRUSES A KEY COMPONENT. THIS YEAR, AS PART OF THIS BOLD INITIATIVE COMMITTING $25M TO END COVID-19 AND DEFEND AGAINST FUTURE RESPIRATORY VIRUSES, WE ANNOUNCED OUR SECOND ROUND OF COVID-19 RESEARCH GRANTS, INCLUDING THE COVID-19 AND RESPIRATORY VIRUS RESEARCH AWARD WHICH PROVIDES $100,000 OF FUNDING A YEAR FOR TWO YEARS. WE ALSO CONTINUED TO SUPPORT PROMISING RESEARCH IN ALL AREAS OF LUNG DISEASE, WITH THE HOPE OF ELIMINATING LUNG DISEASE AND IMPROVING THE LIVES OF THOSE LIVING WITH LUNG DISEASE. OUR RESEARCH PROGRAM INCLUDES OUR AWARDS AND GRANTS PROGRAM AND OUR EXPANDED AIRWAYS CLINICAL RESEARCH CENTERS NETWORK (ACRC), THE LARGEST NOT-FOR-PROFIT CLINICAL RESEARCH NETWORK DEDICATED TO ASTHMA AND COPD IN THE COUNTRY. THIS NETWORK CONDUCTS LARGE PATIENT-FOCUSED CLINICAL TRIALS LED BY SOME OF THE BEST INVESTIGATORS NATIONWIDE TO IMPROVE LUNG HEALTH.WE INCREASED OUR OVERALL RESEARCH FUNDING, INVESTING AN ADDITIONAL $12.6 MILLION, TO ACCELERATE LUNG HEALTH RESEARCH FOR 2021-2022. OUR ANNUAL ADVANCING RESEARCH PUBLICATION ILLUSTRATED OUR ONGOING RESEARCH INITIATIVES, FROM PATIENT STORIES TO SCIENTIFIC ARTICLES, AND RESEARCHER PROFILES AND CREATED A NEW WAY TO KEEP UP WITH OUR CUTTING-EDGE RESEARCH PROGRAM WITH OUR NEW RESEARCH NEWS WEBSITE.IN JUNE 2022, ENROLLMENT BEGAN FOR THE AMERICAN LUNG ASSOCIATION LUNG HEALTH COHORT - THE FIRST-EVER LARGE-SCALE LUNG HEALTH STUDY THAT WILL TRACK 4,000 YOUNG ADULTS (AGES 25-35) AT AN AGE OF PEAK LUNG HEALTH. THE LUNG ASSOCIATION'S AIRWAYS CLINICAL RESEARCH CENTERS NETWORK WILL CONDUCT THE RESEARCH, WORKING CLOSELY WITH RESEARCHERS AT PROMINENT FACILITIES ACROSS THE COUNTRY.THIS YEAR, WE PUBLISHED OUR MAJOR NATIONAL INSTITUTES OF HEALTH FUNDED CLINICAL TRIAL, CONDUCTED BY OUR AIRWAYS CLINICAL RESEARCH CENTERS NETWORK, THE ASTHMA BMI BASELINE STUDY (ABBS), WHICH EVALUATED ASTHMA SYMPTOMS AND THE IMPACT ON QUALITY OF LIFE FOR PEOPLE WHO HAVE POORLY CONTROLLED ASTHMA WITH AN ELEVATED BODY MASS INDEX (BMI). IT CONCLUDED THAT INTERVENTIONS ARE SERIOUSLY NEEDED TO IMPROVE LIFE QUALITY FOR THOSE WITH POORLY CONTROLLED ASTHMA AND OBESITY.THIS YEAR, WE LAUNCHED A NEW LUNG CANCER RESEARCH AWARD. KELLIE SMITH, PH.D., OF JOHNS HOPKINS UNIVERSITY, WAS AWARDED OUR FIRST-EVER PIERRE MASSION LUNG CANCER DISCOVERY AWARD, IN HONOR OF DR. MASSION'S LEGACY. DR. SMITH HOPES TO FIND A WAY TO PREVENT OR DELAY RELAPSES IN PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER. DIVERSITY AND INCLUSION CONTINUE TO BE A KEY NEED IN THE WORLD OF RESEARCH, INCLUDING THE NEED TO IMPROVE ACCESS TO CLINICAL TRIALS. THE BLACK COMMUNITY IS DISPROPORTIONALLY IMPACTED BY LUNG CANCER AND UNDERREPRESENTED IN LUNG CANCER CLINICAL TRIALS. OUR CAMPAIGN "AWARENESS, TRUST AND ACTION" WORKED TO CLOSE THIS GAP BY EDUCATING ABOUT LUNG CANCER CLINICAL TRIALS AND EMPOWERING ALL LUNG CANCER PATIENTS, INCLUDING BLACK AMERICANS, TO PARTICIPATE. TO FURTHER IMPROVE DIVERSITY IN RESPIRATORY CARE, WE SPONSORED A SCHOLAR IN PULMONARY MEDICINE IN THE PRESTIGIOUS HAROLD AMOS MEDICAL FACULTY DEVELOPMENT PROGRAM, DEVELOPED TO INCREASE THE NUMBER OF FACULTY FROM HISTORICALLY MARGINALIZED BACKGROUNDS PURSUING CAREERS IN MEDICINE, DENTISTRY OR NURSING.AS A NEW MEMBER OF THE LUNG ASSOCIATION'S RESEARCH TEAM, FRANCISCO CARTUJANO, M.D., RECEIVED OUR 2021-2022 CATALYST AWARD FOR HIS PROJECT, "KICK VAPING: A VAPING CESSATION TEXT MESSAGING INTERVENTION FOR LATINO YOUNG ADULTS." THE PROJECT AIMS TO DEVELOP AND EVALUATE THE PRACTICALITY AND EFFECTIVENESS OF HIS KICK VAPING INITIATIVE, A TEXT MESSAGING INTERVENTION TO HELP LATINO AND HISPANIC YOUNG ADULTS STOP VAPING. 18046683 846060 ADVOCACY AND ENVIRONMENTAL:EVERY YEAR, THE AMERICAN LUNG ASSOCIATION SUPPORTS POLICIES AND LEGISLATION THAT CAN LEAD TO BETTER LUNG HEALTH ACROSS THE NATION. THESE INCLUDE LAWS THAT PROTECT OUR CHILDREN FROM DEADLY AIR POLLUTION AND TOBACCO PRODUCTS, SUPPORT FUNDING FOR CRITICAL LUNG DISEASE RESEARCH AND HEALTH PROGRAMS AT THE FEDERAL LEVEL, PROVIDE AFFORDABLE, QUALITY HEALTHCARE FOR MORE AMERICANS, AND MUCH MORE. THIS YEAR WE FUNDED MULTIPLE RESEARCH PROJECTS THAT WILL BUILD OUR UNDERSTANDING OF THE MANY WAYS AIR POLLUTION IMPACTS OUR LUNGS. WE ALSO ADVOCATED FOR STRONGER POLICIES TO CLEAN UP AIR POLLUTION AND CURB CLIMATE CHANGE. WE WORKED TO EDUCATE THE PUBLIC, MEDIA AND OUR NATION'S LEADERS ABOUT THE HARMFUL EFFECT DIRTY AIR HAS ON HEALTH AND WHAT WE NEED TO DO TO CLEAN IT UP. ADVOCATING FOR HEALTHY AIR WAS EVEN MORE IMPORTANT DURING THE COVID-19 PANDEMIC AS RESEARCH SHOWED THAT EXPOSURE TO AIR POLLUTION WAS LINKED TO WORSENED IMPACTS FROM COVID-19.IN LATE 2021, WE SAW THE IMPACT OF OUR CLEAN AIR ADVOCACY WITH TWO IMPORTANT LEGISLATIVE ACTIONS ON OZONE AND METHANE POLLUTION. THE ENVIRONMENTAL PROTECTION AGENCY (EPA) SHARED ITS DECISION TO RECONSIDER THE INADEQUATE OZONE STANDARD THAT THE PREVIOUS ADMINISTRATION PUSHED. THE LUNG ASSOCIATION AND PARTNERS SUED EPA OVER THE WEAK STANDARD AND URGED THE AGENCY TO RECONSIDER. WE ALSO ADVOCATED FOR THE REDUCTION OF METHANE POLLUTION FROM THE OIL AND GAS SECTOR, WHICH IS RAPIDLY ACCELERATING CLIMATE CHANGE AND CREATING TOXIC AIR POLLUTION. IN NOVEMBER 2021, EPA RELEASED A PROPOSED RULE TO CUT METHANE AND OTHER HARMFUL POLLUTANTS FROM NEW AND EXISTING OIL AND GAS OPERATIONS. CLIMATE CHANGE HAS MADE WILDFIRE MORE FREQUENT AND SEVERE. WE ADDRESSED THE EVER-WORSENING THREAT OF WILDFIRES IN A NEW REPORT "CAN PRESCRIBED FIRES MITIGATE HEALTH HARM?" THAT WEIGHS THE BENEFITS AND RISKS OF PRESCRIBED FIRES TO REDUCE HEALTH HARMS OF CATASTROPHIC WILDFIRES. FUELED BY CLIMATE CHANGE, WILDFIRES ARE BECOMING MORE FREQUENT AND INTENSE INCREASINGLY EXPOSING MORE AMERICANS TO THE POTENTIALLY DEADLY EFFECTS OF BREATHING WILDFIRE SMOKE. EARLY IN 2022, WE CELEBRATED A CLEAR VICTORY WHEN EPA FINALIZED STRONGER CAR EMISSION STANDARDS ON GREENHOUSE GAS EMISSIONS FOR LIGHT-DUTY VEHICLES FOR MODEL YEARS 2023-2026. HOWEVER, WE WERE DISAPPOINTED BY THE U.S. SUPREME COURT DECISION IN THE CASE OF WEST VIRGINIA V. EPA, WHICH LIMITS EPA'S AUTHORITY TO REGULATE GREENHOUSE GAS EMISSIONS FROM COAL AND OIL-FIRED POWER PLANTS. WE WILL CONTINUE TO ADVOCATE TO OVERTURN THIS DECISION AND RESTORE EPA'S POWER TO PROTECT OUR HEALTH.QUALITY AND AFFORDABLE HEALTHCARE ACCESS IS CRUCIAL TO ALL AMERICANS, ESPECIALLY LUNG DISEASE PATIENTS. IN JULY 2021, WE HOSTED OUR LEADING FOR LUNGS DAY OF ACTION TO URGE CONGRESS TO FURTHER EXPAND ACCESS TO QUALITY AND AFFORDABLE HEALTHCARE AND MAKE TRANSFORMATIVE INVESTMENTS IN CLEAN ENERGY, CLEAN TRANSPORTATION AND ENVIRONMENTAL JUSTICE TO ADDRESS AIR POLLUTION AND CLIMATE CHANGE. IN SEPTEMBER 2021, LUNG ASSOCIATION VOLUNTEER ADVOCATES HELD TWELVE VIRTUAL MEETINGS WITH KEY SENATE OFFICES, AND MANY MORE JOINED IN WITH OUR BRAND-NEW TOOL THAT MAKES IT EASY AND AUTOMATIC TO CONNECT WITH YOUR MEMBERS OF CONGRESS. WHEN HEALTHCARE ENROLLMENT OPENED IN NOVEMBER, AND THEN EXPANDED AT HEALTHCARE.GOV, WE ROLLED OUT A SERIES OF UPDATED TOOLS TO HELP PEOPLE UNDERSTAND THEIR CHOICES AND THE ENROLLMENT PROCESS. THIS YEAR, OUR HEALTHY AIR CAMPAIGN CONTINUED TO FIGHT FOR HEALTHY AIR FOR ALL AMERICANS. WE CONTINUED OUR FOCUS ON REDUCING TAILPIPE POLLUTION WITH THE RELEASE OF OUR "ZEROING IN ON HEALTHY AIR" REPORT, WHICH ADDRESSED THE HEALTH AND CLIMATE BENEFITS OF A WIDESPREAD SHIFT TO ZERO-EMISSION CARS, BUSES AND TRUCKS. IT ALSO SHINED A LIGHT ON LIVES THAT COULD BE SAVED, THE DOLLAR VALUE OF CLIMATE IMPACTS AVOIDED AND MORE. AS PART OF OUR ADVOCACY EFFORTS TO CONVINCE CONGRESS TO INVEST IN TRANSITIONING SCHOOL BUSES NATIONWIDE FROM DIESEL TO ELECTRIC, WE HELD A STAND-UP PRESS CONFERENCE IN SEPTEMBER 2021, ON CAPITOL HILL. WITH AN ELECTRIC SCHOOL BUS AS OUR BACKDROP, SENATOR TOM CARPER, OTHER MEMBERS OF CONGRESS, AND REPRESENTATIVES FROM NATIONAL CHILDREN'S HEALTH AND NURSING ORGANIZATIONS JOINED US TO SPEAK. EACH HIGHLIGHTED THE HEALTH BENEFITS OF ZERO-EMISSION, ELECTRIC SCHOOL BUSES AND CALLED ON CONGRESS TO MAKE THE SWITCH. A LETTER SIGNED BY 500 HEALTH PROFESSIONALS AND SENT TO CONGRESS HELPED DRIVE THE POINT HOME.IN APRIL 2022, WE RELEASED THE 23RD EDITION OF OUR ANNUAL "STATE OF THE AIR" REPORT. THIS YEAR'S REPORT SHOWED THAT DESPITE SOME NATIONWIDE PROGRESS ON CLEANING UP AIR POLLUTION, MORE THAN 40% OF AMERICANS LIVE WITH UNHEALTHY OZONE OR PARTICLE POLLUTION. THE REPORT FINDS THAT PEOPLE OF COLOR ARE SIGNIFICANTLY MORE LIKELY TO BREATHE POLLUTED AIR THAN WHITE PEOPLE. AS THE NATION WORKS TO ADDRESS CLIMATE CHANGE AND CONTINUE REDUCING AIR POLLUTION, WE MUST PRIORITIZE THE HEALTH OF DISPROPORTIONATELY BURDENED COMMUNITIES. 87603320 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 435 0 647 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 19 19 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS NH NJ NM NY NC ND OH OK OR PA RI SC TN VA WA WV WI X X LAURA SCOTT CFO 2177875864 3000 KELLY LANE SPRINGFIELD IL 62711 HAROLD WIMMER PRESIDENT & CEO 40.00 X 547872 0 60007 JEFF SEYLER CHEIF DIVISION OFFICER, EAST 40.00 X 272977 0 38462 JULIA FITZGERALD CHIEF MARKETING OFFICER 40.00 X 273156 0 35312 LAURA SCOTT CHEIF FINANCIAL OFFICER 40.00 X 276560 0 24907 SUE SWAN CHIEF DEVELOPMENT OFFICER 40.00 X 254829 0 45829 DEBORAH BROWN CHEIF MISSION OFFICER 40.00 X 257452 0 36378 WILLIAM PFEIFER EXE. VP, GOVERNANCE & STRATEGIC INITIATIVES 40.00 X 249260 0 38273 SARAH KRIKORIAN CHEIF HUMAN RESOURCES OFFICER 40.00 X 244700 0 32287 PAUL BILLINGS NATIONAL SENIOR VP, PUBLIC POLICY 40.00 X 219024 0 23335 SALLY DRAPER NATIONAL SVP, DEVELOPMENT, CORPORATE & FOUNDATION 40.00 X 208048 0 13248 ALLISON HICKEY EXECUTIVE VP, MOUNTAIN PACIFIC & CA 40.00 X 205857 0 14115 SUSAN RAPPAPORT NATIONAL VICE PRESIDENT, RESEARCH 40.00 X 194520 0 20587 NEIL BALLENTINE CHIEF TECHNOLOGY OFFICER 40.00 X 180223 0 26729 EMILY MURPHY DIVISION SENIOR VP, DEVELOPMENT 40.00 X 173864 0 14887 LEWIS BARTFIELD CHEIF DIVISION OFFICER, WEST 40.00 X 157356 0 23833 STEPHEN R O'KANE CHAIR 2.00 X X 0 0 0 PENNY J SCHILZ PAST CHAIR (THRU 6/2022) 2.00 X X 0 0 0 CHERYL A CALHOUN CPA MBA CHAIR-ELECT, DIRECTOR 2.00 X X 0 0 0 MICHAEL V CARSTENS SECRETARY / TREASURER 2.00 X X 0 0 0 SUMITA B KHATRI MD MS VICE CHAIR, MISSIONS PROGRAM 2.00 X 0 0 0 FELIX AGUILAR MD MPH DIRECTOR 2.00 X 0 0 0 RABIH I BECHARA MD FCCP DIRECTOR 2.00 X 0 0 0 LARRY BLUMENTHAL MBA DIRECTOR (THRU 6/2022) 2.00 X 0 0 0 ANNE E DIXON MD DIRECTOR 2.00 X 0 0 0 DAVID G HILL MD DIRECTOR 2.00 X 0 0 0 MARK C JOHNSON CFA MBA DIRECTOR 2.00 X 0 0 0 COLLEEN M MCINTOSH JD LLM DIRECTOR 2.00 X 0 0 0 SEAN R MULDOON MD MPH FCCP DIRECTOR 2.00 X 0 0 0 JOE OCHIPINTI DIRECTOR 2.00 X 0 0 0 JONATHON K ROSEN BA DIRECTOR 2.00 X 0 0 0 KATHLEEN M SKAMBIS JD MBA DIRECTOR (THRU 6/2022) 2.00 X 0 0 0 JOHNNY A SMITH JR MA VICE CHAIR 2.00 X X 0 0 0 VICTOR WATERS MD JD FCLM DIRECTOR (THRU 8/2022) 2.00 X 0 0 0 STERLING QL YEE MBA DIRECTOR 2.00 X 0 0 0 3715698 0 448189 69 0 1 0 PRODUCTION SOLUTIONS 1953 GALLOWS RD SUITE 500 VIENNA VA 22182 MARKETING 5125242 RR DONNELLEY 35 W WACKER DRIVE CHICAGO IL 60601 MARKETING 2754325 AD COUNCIL 815 SECOND AVENUE 9TH FLOOR NEW YORK NY 10017 PUBLIC SERVICE ADVERTISING 1831006 RESCUE AGENCY PUBLIC BENEFIT LLC 2437 MORENA BLVD SAN DIEGO CA 92110 MARKETING 1747863 INNOVAIRREBRICKMILL MARKETING SERVICES 2 EXECUTIVE CAMPUS SUITE 200 CHERRY HILL NJ 08002 MARKETING 1454830 73 12490910 40800448 58999806 144416 112291164 PROGRAM SERVICE CONTRACTS 541900 1365453 1365453 PROGRAM PARTICIPANT FEE 541900 1058318 1058318 MEMBERSHIP DUES 541900 89262 89262 2513033 5058083 5058083 3175287 3175287 167547 0 167547 167547 167547 18454625 697944 13893146 454795 4561479 243149 4804628 4804628 2837732 12490910 3048500 -210768 -210768 RESEARCH GRANT SERVICE FEE 541900 1295198 1295198 298764 298764 1593962 129392936 4106995 0 12994777 X 13235010 13235010 2991257 2632306 89737 269214 30626907 26096309 786929 3743669 2376711 2023633 64995 288083 3589933 3062035 98671 429227 2341195 1999188 64560 277447 446755 446755 88715 88715 25472268 24767730 281942 422596 1079446 821015 197 258234 1376212 1057608 86228 232376 3296344 2544500 261480 490364 565209 510241 4387 50581 77712 64045 7969 5698 351157 351157 401800 303841 33899 64060 DIRECT MAIL 12709611 7879959 635480 4194172 MISCELLANEOUS 651428 432709 29238 189481 POSTAGE & SHIPPING 132524 95211 4405 32908 PRINTING 116511 77980 1222 37309 101926705 87603320 2891211 11432174 X 12709611 7879959 635480 4194172 136720 144821 30204501 27213680 10646065 17309277 306570 10687 51376 121536 1767757 2298896 21343030 10305260 9820065 11037770 136781279 120122477 43099490 36789972 232813823 215049116 11029182 12591730 12436934 12257372 15923513 11447314 0 1781745 24985453 11307430 64375082 49385591 X 118316552 121282464 50122189 44381061 168438741 165663525 232813823 215049116 X 27466231 -26178722 -4062725 X X 0 1 X 1 1 1 X 90355569 93429565 89851926 83540236 112291164 469468460 90355569 93429565 89851926 83540236 112291164 469468460 10211588 459256872 4736244 4659481 4822544 4656339 8400917 27275525 6592177 5053253 452244 311677 12409351 509153336 32516313 0.90200 0.87320 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2017 AMOUNT: $ 547,995. 2018 AMOUNT: $ 808,279. 2019 AMOUNT: $ 452,244. 2020 AMOUNT: $ 311,677. RESEARCH GRANT SERVICE FEE - 2017 AMOUNT: $ 1,378,900. 2018 AMOUNT: $ 408,500. TRUST INCOME - 2017 AMOUNT: $ 2,353,015. 2018 AMOUNT: $ 1,706,953. PROGRAM PARTICIPANT FEES - 2017 AMOUNT: $ 2,312,267. 2018 AMOUNT: $ 2,129,521. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 1 51814 1 6835 1 1768 1 119739 1 475501 1 19873 0 675530 0 PART II-B, LINE 1: THE AMERICAN LUNG ASSOCIATION VOLUNTEERS AND STAFF ENGAGE IN A WIDE RANGE OF ADVOCACY ACTIVITIES TO FURTHER OUR MISSION TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. OUR WORK INCLUDES EFFORTS TO EDUCATE ELECTED OFFICIALS, THEIR STAFF AND THE PUBLIC ON LUNG HEALTH ISSUES AND ACCESS TO HEALTHCARE. WE ADVOCATE FOR CLEAN, HEALTHY AIR TO REDUCE THE HEALTH IMPACTS OF AIR POLLUTION AND CURB CLIMATE CHANGE. WE FOCUS ON SUPPORTING THE IMPLEMENTATION AND STRENGTHENING OF THE NATION'S CLEAN AIR LAWS. WE STRONGLY SUPPORT THE PUBLIC HEALTH INFRASTRUCTURE AND LUNG HEALTH RESEARCH FUNDING INCLUDING FUNDING FOR LUNG CANCER, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ASTHMA, TUBERCULOSIS AND OTHER LUNG DISEASES. FURTHERMORE, THE AMERICAN LUNG ASSOCIATION VOLUNTEERS AND STAFF ACTIVELY ADVOCATE AT THE NATIONAL, STATE AND LOCAL LEVELS FOR TOBACCO CONTROL LAWS, INCLUDING EFFORTS TO REGULATE TOBACCO PRODUCTS INCLUDING E-CIGARETTES, PROMOTE TOBACCO CESSATION AND ELIMINATE EXPOSURE TO SECONDHAND SMOKE. 9016928 5300 -952335 99662 7970231 8600852 5000 1326442 915366 9016928 8779996 6100 -40790 144454 8600852 7773457 1003500 256966 253927 8779996 1207060 7380831 467650 1261111 20973 7773457 1.00000 0 0 2582203 2582203 14499820 6293769 8206051 455278 320709 134569 3805729 3690782 114947 11037770 BENEFICIAL INTEREST IN PERPETUAL TRUSTS 35382670 AMOUNTS HELD ON BEHALF OF OTHERS 1148660 REFUNDABLE DEPOSITS 258642 36789972 PENSION & LIFE INSURANCE BENEFITS 8799532 AMOUNTS HELD ON BEHALF OF OTHERS 1148660 ANNUITY FUND INVESTMENTS 893806 OTHER LIABILITIES 465432 11307430 X 135196629 -26178722 36133855 -4062725 5892408 129304221 88715 88715 129392936 137971845 36133855 36133855 101837990 88715 88715 101926705 PART V, LINE 4: PROCEEDS EARNED FROM THE CORPUS OF THESE NUMEROUS ENDOWMENT FUNDS MAY BE EXPENDED FOR RESEARCH, RESEARCH FELLOWSHIPS, LUNG-HEALTH EDUCATION, CONTINUING MEDICAL EDUCATION LECTURES, SCHOLARSHIPS, PATIENT ASSISTANCE, ADVOCACY, TOBACCO CESSATION ASSISTANCE, AND GENERAL OPERATIONS IN ACCORDANCE WITH DONOR STIPULATIONS. PART X, LINE 2: THE ASSOCIATION IS DESIGNATED AS A NON-PROFIT ORGANIZATION AND IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. IT HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION. THEREFORE, CHARITABLE CONTRIBUTIONS ARE TAX DEDUCTIBLE. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN FAIR VALUE OF BENEFICIAL INTEREST IN TRUSTS -5,849,144. CHANGE IN VALUE OF SPLIT-INTEREST TRUSTS -162,165. CHANGE IN VALUE OF EQUITY METHOD INVESTMENTS -162,511. PENSION AND POSTRETIREMENT PLAN CHANGES 2,111,095. X X X 1 NNE MARKETING 1666 MASSACHUSETTS AVE SUITE 14 LEXINGTON MA 02420 DIRECT MARKETING 0 17971258 369000 17602258 GATEWAY COMMUNICATIONS 16805 NE MASON COURT PORTLAND OR 97230 TELEMARKETING SERVICES 0 78985 77755 1230 18050243 446755 17603488 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC FIGHT FOR AIR CLIMB 6248230 6248230 50384 351336 30171 12430 398581 LUNG FORCE WALKS 2481036 2481036 5483 49254 7740 13433 202779 46 6599376 3761644 2837732 96655 329333 438031 35661 1027229 15328642 12490910 2837732 152522 729923 475942 61524 1628589 3048500 -210768 SCHEDULE G, PART I, LINE 2B, COLUMN (V) THE AMERICAN LUNG ASSOCIATION ACQUIRES CONTRIBUTIONS FROM DIRECT MAIL AND TELEMARKETING SERVICES. IN ORDER TO MANAGE THESE ACTIVITIES, THE AMERICAN LUNG ASSOCIATION CONTRACTS WITH PROFESSIONAL FUNDRAISERS TO DEVELOP FUNDRAISING STRATEGIES ON THESE INITIATIVES. 1 REGENTS OF THE UNIVERSITY OF MINNESOTA 2221 UNIV AVENUE SE STE 100 MINNEAPOLIS MN 55414 416007513 501(C)(3) 100000 0 RESEARCH UNIVERSITY OF MICHIGAN 3003 S STATE STREET 5082 WOLVERINE TOWER ANN ARBOR MI 48109 386006309 501(C)(3) 418743 0 RESEARCH ST VINCENT OF INDIANA 1 HOSPITAL DRIVE INDIANAPOLIS IN 46260 350869066 501(C)(3) 156329 0 RESEARCH NEMOURS CHILDREN CLINIC 10140 CENTURION PARKWAY NORTH JACKSONVILLE FL 32256 590634433 501(C)(3) 190389 0 RESEARCH ENTERTAINMENT INDUSTRY FOUNDATION (STAND UP 2 CANCER) 10880 WILSHIRE BOULEVARD SUITE 1400 LOS ANGELES CA 90024 951644609 501(C)(3) 1500000 0 RESEARCH REGENTS UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BOULEVARD SUITE 700 LOS ANGELES CA 900951406 956006143 501(C)(3) 400000 0 RESEARCH CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVENUE CLEVELAND OH 441067037 341018992 501(C)(3) 100000 0 RESEARCH NATIONAL COMMITTEE FOR QUALITY ASSURANCE (NCQA) 1100 13TH STREET NW THIRD FLOOR WASHINGTON DC 20005 521191985 501(C)(3) 96987 0 RESEARCH UNIVERSITY HOSPITALS CLEVELAND MEDICAL CTR 11100 EUCLID AVENUE CLEVELAND OH 44106 341567805 501(C)(3) 200000 0 RESEARCH THOMAS JEFFERSON UNIVERSITY 125 S 9TH STREET SUITE 600 PHILADELPHIA PA 19107 231352651 501(C)(3) 100000 0 RESEARCH UNIVERSITY OF COLORADO DENVER 13001 E 17TH PLACE BUILDING 500 AURORA CO 80045 846000555 501(C)(3) 200000 0 RESEARCH NATIONAL JEWISH MEDICAL AND RESEARCH CENTER 1400 JACKSON STREET DENVER CO 80206 742044647 501(C)(3) 227314 0 RESEARCH UNIVERSITY OF TEXAS MD ANDERSON CANCER CTR 1515 HOLCOMBE BOULEVARD HOUSTON TX 770307009 746001118 501(C)(3) 200000 0 RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 746001118 501(C)(3) 150000 0 RESEARCH EMORY UNIVERSITY 1599 CLIFTON ROAD 4TH FLOOR ATLANTA GA 303224250 580566256 501(C)(3) 100000 0 RESEARCH TEMPLE UNIVERSITY 1852 N 10TH STREET PHILADELPHIA PA 19122 231365971 501(C)(3) 236109 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM STREET SAN FRANCISCO CA 94143 946036493 501(C)(3) 333119 0 RESEARCH CHILDRENS NATIONAL MEDICAL CENTER 1935 MEDICAL DISTRICT DRIVE DALLAS TX 75235 750800628 501(C)(3) 150000 0 RESEARCH YALE UNIVERSITY 2 WHITNEY AVENUE 6TH FLOOR NEW HAVEN CT 06510 060646973 501(C)(3) 100000 0 RESEARCH GATEWAY FOR CANCER RESEARCH 20 NORTH MARTINGALE ROAD SUITE 180 SCHAUMBURG IL 60173 731386920 501(C)(3) 400000 0 RESEARCH UNIVERSITY OF KANSAS CTR FOR RESEARCH 2385 IRVING HILL ROAD LAWRENCE KS 66045 480680117 501(C)(3) 235599 0 RESEARCH AMERICAN THORACIC SOCIETY INC 25 BROADWAY 4TH FLOOR NEW YORK NY 10004 061548706 501(C)(3) 271710 0 RESEARCH UNIVERSITY OF HAWAII 2538 MCCARTHY MALL EDMONDSON 216 HONOLULU HI 86822 996000354 501(C)(3) 150000 0 RESEARCH UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON 301 UNIVERSITY BOULEVARD GALVESTON TX 775551166 746000949 501(C)(3) 200000 0 RESEARCH SEATTLE BIOMEDICAL RESEARCH INSTITUTE 307 WESTLAKE AVENUE SEATTLE WA 98109 911452438 501(C)(3) 154029 0 RESEARCH UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC 310 E CAMPUS ROAD ATHENS GA 30602 581353149 501(C)(3) 100000 0 RESEARCH UNIVERSITY OF FLORIDA 33 TIGERT HALL GAINESVILLE FL 32611 596002052 501(C)(3) 150000 0 RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICH ROAD N4 327-B BALTIMORE MD 21211 520595110 501(C)(3) 1170000 0 RESEARCH UNIVERSITY OF ARKANSAS FOR MEDICAL SERVICES 4301 WEST MARKHAM STREET ST LITTLE ROCK AR 72205 716046242 501(C)(3) 150000 0 RESEARCH WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 455 MAIN STREET CAMBRIDGE MA 02142 061043412 501(C)(3) 100000 0 RESEARCH SEATTLE CHILDREN'S HOSPITAL 4800 SAND POINT WAY NE SEATTLE WA 981053901 910564748 501(C)(3) 200000 0 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 041564655 501(C)(3) 258709 0 RESEARCH NEW YORK UNIVERSITY SCHOOL OF MEDICINE 550 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 200000 0 RESEARCH THE UNIVERSITY OF CHICAGO 5801 ELLIS AVENUE CHICAGO IL 60637 362177139 501(C)(3) 200000 0 RESEARCH COLUMBIA UNIVERSITY 615 WEST 131ST STREET NEW YORK NY 10027 135598093 501(C)(3) 193549 0 RESEARCH NORTHWESTERN UNIVERSITY 619 CLARK STREET EVANSTON IL 60208 362167817 501(C)(3) 343984 0 RESEARCH UNIVERSITY OF TENNESSEE (HEALTH SCIENCE CTR) 62 SOUTH DUNLAP STREET SUITE 300 MEMPHIS TN 38163 626001636 501(C)(3) 200000 0 RESEARCH WASHINGTON UNIVERSITY 700 ROSEDALE AVENUECAMPUS BOX 1034 ST LOUIS MO 631121408 430653611 501(C)(3) 47500 0 RESEARCH THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO 7703 FLOYD CURL DRIVE MC7828 SAN ANTONIO TX 782293900 741586031 501(C)(3) 15389 0 RESEARCH VIRGINIA COMMONWEALTH UNIVERSITY 800 E LEIGH STREET SUITE 3100 RICHMOND VA 23284 546001758 501(C)(3) 200000 0 RESEARCH BOARD OF TRUSTEES OF THE UNIVERISTY OF ILLINOIS 809 S MARSHFIELD AVENUE M/C 551 CHICAGO IL 606127502 376000511 501(C)(3) 75000 0 RESEARCH UNIVERSITY OF VERMONT 85 SOUTH PROSPECT STREET BURLINGTON VT 05405 030179440 501(C)(3) 414279 0 RESEARCH THE OHIO STATE UNIVERSITY 901 WOODY HAYES DRIVE 2020 BLANKENSHIP HALL COLUMBUS OH 43210 316025986 501(C)(3) 301500 0 RESEARCH GEORGIA TECH RESEARCH CORPORATION 926 DALNE STREET NW ATLANTA GA 303320415 580603146 501(C)(3) 150000 0 RESEARCH UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION CONTROLLERS OFFICE SERVICE COMPLES BUILDING LOUISVILLE KY 40292 611029626 501(C)(3) 200000 0 RESEARCH BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 770303411 741613878 501(C)(3) 214239 0 RESEARCH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE BOX 3500 NEW YORK NY 100296574 136171197 501(C)(3) 247500 0 RESEARCH DUKE UNIVERSITY PO BOX 104132 DURHAM NC 27708 560532129 501(C)(3) 441078 0 RESEARCH WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY PO BOX 22371 NEW YORK NY 100872371 131623978 501(C)(3) 200000 0 RESEARCH BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA HEALTH SCIENCE CTR PO BOX 26901 RP865 ROOM 560 OKLAHOMA CITY OK 731260901 731563627 501(C)(3) 150000 0 RESEARCH UNIVERSITY OF ARIZONA PO BOX 3308 TUCSON AZ 85722 742652689 501(C)(3) 173034 0 RESEARCH UNIVERSITY OF SOUTHERN CALIFORNIA UNIVERSITY GARDENS BUILDING STE 205 LOS ANGELES CA 900898006 951642394 501(C)(3) 400000 0 RESEARCH UNIVERSITY OF ALABAMA AT BIRMINGHAM UNIVERSITY STATION BIRMINGHAM AL 35294 636005396 501(C)(3) 464289 0 RESEARCH RETURNED FUNDS & CANCELLED PAYMENTS - VARIOUS UNIVERSITIES 55 W WACKER DRIVE CHICAGO IL 60601 131632524 501(C)(3) -95368 0 RESEARCH 53 0 PART I, LINE 2: AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A RENEWAL APPLICATION AFTER THEIR FIRST YEAR OF FUNDING. RENEWAL APPLICATIONS ARE THEN REVIEWED BY OUR RESEARCH COMMITTEE CHAIRS FOR APPROVAL OF SECOND YEAR FUNDING. AT THE TIME OF TERMINATION (AFTER THE SECOND YEAR OF FUNDING), AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A SUMMARY OF THEIR ACTIVITIES, COPIES OF PRESENTATIONS AND/OR PUBLICATIONS, AND A CASH DISBURSEMENT REPORT FOR THE ENTIRE GRANT TIME. X X X X X X 0 1 0 0 0 0 0 0 0 HAROLD WIMMER PRESIDENT & CEO 522872 0 25000 0 0 0 30397 0 29610 0 607879 0 0 0 JEFF SEYLER CHEIF DIVISION OFFICER, EAST 253226 0 19751 0 0 0 28138 0 10324 0 311439 0 0 0 JULIA FITZGERALD CHIEF MARKETING OFFICER 253380 0 19776 0 0 0 15808 0 19504 0 308468 0 0 0 LAURA SCOTT CHEIF FINANCIAL OFFICER 256810 0 19750 0 0 0 22934 0 1973 0 301467 0 0 0 SUE SWAN CHIEF DEVELOPMENT OFFICER 236725 0 18104 0 0 0 25960 0 19869 0 300658 0 0 0 DEBORAH BROWN CHEIF MISSION OFFICER 238986 0 18466 0 0 0 25170 0 11208 0 293830 0 0 0 WILLIAM PFEIFER EXE. VP, GOVERNANCE & STRATEGIC INIT 242658 0 6602 0 0 0 25866 0 12407 0 287533 0 0 0 SARAH KRIKORIAN CHEIF HUMAN RESOURCES OFFICER 227500 0 17200 0 0 0 13405 0 18882 0 276987 0 0 0 PAUL BILLINGS NATIONAL SENIOR VP, PUBLIC POLICY 211775 0 7249 0 0 0 23335 0 0 0 242359 0 0 0 SALLY DRAPER NATIONAL SVP, DEVELOPMENT, CORPORATE 198486 0 9562 0 0 0 13248 0 0 0 221296 0 0 0 ALLISON HICKEY EXECUTIVE VP, MOUNTAIN PACIFIC & CA 199958 0 5899 0 0 0 14115 0 0 0 219972 0 0 0 SUSAN RAPPAPORT NATIONAL VICE PRESIDENT, RESEARCH 190768 0 3752 0 0 0 20587 0 0 0 215107 0 0 0 NEIL BALLENTINE CHIEF TECHNOLOGY OFFICER 168175 0 12048 0 0 0 13792 0 12937 0 206952 0 0 0 EMILY MURPHY DIVISION SENIOR VP, DEVELOPMENT 167272 0 6592 0 0 0 14887 0 0 0 188751 0 0 0 LEWIS BARTFIELD CHEIF DIVISION OFFICER, WEST 157356 0 0 0 0 0 17664 0 6169 0 181189 0 0 0 PART I, LINE 4B HAROLD WIMMER RECEIVED $35,057 FROM A 457(F) PLAN. X SUPPLIES 50 144416 FMV 0 1 0 FORM 990, PART VI, SECTION A, LINE 1A EXECUTIVE COMMITTEE: THE EXECUTIVE COMMITTEE SHALL ACT IN PLACE OF AND WITH THE FULL AUTHORITY OF THE BOARD OF DIRECTORS WHEN THE BOARD OF DIRECTORS IS NOT IN SESSION, SUBJECT TO THE BOARD'S POWER TO AMEND OR CHANGE THOSE ACTIONS WHICH HAVE NOT BEEN IMPLEMENTED PRIOR TO THE BOARD MEETING OR MEETINGS FOLLOWING THE EXECUTIVE MEETING AT WHICH SUCH ACTION WAS TAKEN. THE BOARD OF DIRECTORS HAS THE POWER TO AUTHORIZE AND DELEGATE TO THE EXECUTIVE COMMITTEE TO THE EXTEND PERMITTED BY THE ASSOCIATION'S BYLAWS AND APPLICABLE LAW. THE EXECUTIVE COMMITTEE SHALL NOT HAVE THE AUTHORITY TO APPOINT OFFICERS EXCEPT ON AN INTERIM BASIS TO FILL A VACANCY, ENTER INTO OR AMEND CONTRACTS WITH OFFICERS, AMEND THE POLICIES MANUAL, OR BORROW MONEY IN EXCESS OF THE AMOUNTS EXPRESSLY AUTHORIZED BY THE BOARD. THE EXECUTIVE COMMITTEE SHALL HAVE NO AUTHORITY TO AMEND THE ARTICLES OF INCORPORATION, ADOPT A PLAN OF MERGER OR CONSOLIDATION, AUTHORIZE THE SALE OR OTHER DISPOSITION OF ALL OR SUBSTANTAILLY ALL OF THE PROPERTY AND ASSETS OF THE ASSOCIATION, AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE ASSOCIATION OR REVOCATION OF SUCH DISSOLUTION, OR AMEND THE BYLAWS OF THE ASSOCIATION. THE EXECUTIVE COMMITTEE MAY ESTABLISH A LEADERSHIP SUBCOMMITTEE CONSISTING OF THE CHAIR, VICE-CHAIR, AND PAST-CHAIR, WHICH SHALL SERVE AS THE EXECUTIVE COMMITTEE'S LIAISON TO THE PRESIDENT AND CEO. THE GOVERNANCE COMMITTEE, TAKING INTO ACCOUNT GEOGRAPHY, EXPERTISE, RACE, ETHNICITY, GENDER, AGE AND OTHER DIVERSITY FACTORS, SHALL PRESENT ANNUALLY TO THE BOARD OF DIRECTORS ITS RECOMMENDED NOMINEES FOR MEMBERS OF THE BOARD OF DIRECTORS, MEMBERS OF THE GOVERNANCE COMMITTEE AND OFFICERS (OTHER THAN THE PRESIDENT AND CHIEF EXECUTIVE OFFICER) OF THE ASSOCIATION (INCLUDING A RECOMMENDATION WHERE APPROPRIATE, FOR THE DESIGNATION OF THE VICE-CHAIR AS CHAIR-ELECT). OTHER NOMINATIONS MAY NOT BE MADE AT THE MEETING OF THE BOARD OF DIRECTORS FROM THE FLOOR. FORM 990, PART VI, SECTION B, LINE 11B AMERICAN LUNG ASSOCIATION HAS ESTABLISHED THE FOLLOWING REVIEW PROCESS TO ENSURE THAT THE INFORMATION REPORTED IS COMPLETE AND ACCURATE. FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND REVIEWED BY THE CFO. PRIOR TO ELECTRONIC SUBMISSION, IT IS REVIEWED BY THE ORGANIZATION'S DELEGATED RESPONSIBLE BODY, THE AUDIT AND RISK OVERSIGHT COMMITTEE, FOR APPROVAL. AFTER APPROVAL BY THE AROC COMMITTEE, THE MEMBERS OF THE GOVERNING BODY REVIEW THE FORM PRIOR TO SUBMISSION. ALL COMMENTS ARE DOCUMENTED, ADDRESSED AND FINALIZED BEFORE SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C ALA CURRENTLY HAS IN PLACE A CONFLICT OF INTEREST POLICY WHICH IT MONITORS AND ENFORCES ANNUALLY AND HAS A STANDING GOVERNANCE COMMITTEE THAT OVERSEES ITS EXECUTION. THE ORGANIZATION CURRENTLY MANDATES THAT ALL MEMBERS OF THE GOVERNING BODY, COMMITTEE MEMBERS AND ALL STAFF ANNUALLY SIGN A CONFLICT OF INTEREST POLICY AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS THAT MAY EXIST. THE SIGNED CONFLICT OF INTEREST POLICY STATEMENTS ARE SUBMITTED TO THE GOVERNANCE COMMITTEE. THESE STATEMENTS ARE REVIEWED FOR POTENTIAL OR ACTUAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15 THE AMERICAN LUNG ASSOCIATION HAS ESTABLISHED A COMPENSATION POLICY FOR ITS LEADERSHIP COMMITTEE TO FOLLOW IN ESTABLISHING THE COMPENSATION FOR ITS CFO, TOP MANAGEMENT OFFICIAL, OTHER OFFICERS OR KEY EMPLOYEES. THE POLICY MANDATES THAT EXECUTIVE COMPENSATION BE PERIODICALLY REVIEWED BY THE COMMITTEE AND THAT THE COMMITTEE SHOULD BE FREE OF CONFLICTS OF INTEREST. IN ADDITION, THE APPROVING COMMITTEE NEEDS TO REVIEW APPROPRIATE AND ADEQUATE DATA TO DETERMINE THE REASONABLENESS OF THE COMPENSATION BEING CONSIDERED. THE COMMITTEE MAY USE A VARIETY OF INFORMATION AND STUDIES THAT ARE AVAILABLE TO DETERMINE THAT THE APPROPRIATE LEVEL OF COMPENSATION IS BEING PAID TO ITS EXECUTIVES. THE COMMITTEE'S DECISION ON THE AMOUNT OF COMPENSATION PAID IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT AND DOCUMENTS THE DATE OF THE DECISION, THE MEMBERS PRESENT DURING THE MEETING AND THOSE WHO VOTED ON IT. THE DETAILS OF THE TRANSACTION THAT WAS APPROVED AND THE COMPARABILITY DATA USED AND RELIED UPON TO MAKE THE DECISION. ALA CONDUCTS PERIODIC COMPENSATION REVIEW FOR THE CEO AS WELL AS OTHER OFFICERS AND KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE THREE MOST RECENT YEARS OF FORM 990 AND ANNUAL REPORTS ARE AVAILABLE ON AMERICAN LUNG ASSOCIATION'S WEBSITE, WWW.LUNG.ORG. GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE TO THE PUBLIC UPON REQUEST. OUR WEBSITE ALSO PROVIDES THE NAMES OF OUR BOARD OF DIRECTORS AND OUR ETHICS POLICY. FORM 990, PART IX, LINE 11G PROGRAM CONSULTING : PROGRAM SERVICE EXPENSES 19,286,066. TOTAL EXPENSES 19,286,066. OTHER FEES: PROGRAM SERVICE EXPENSES 5,481,664. MANAGEMENT AND GENERAL EXPENSES 281,942. FUNDRAISING EXPENSES 422,596. TOTAL EXPENSES 6,186,202. FORM 990, PART XI, LINE 9: CHANGE IN FAIR VALUE OF BENEFICIAL INTEREST IN TRUSTS -5,849,144. CHANGE IN VALUE OF SPLIT-INTEREST TRUSTS -162,165. CHANGE IN VALUE OF EQUITY METHOD INVESTMENTS -162,511. PENSION AND RETIREMENT PLAN CHANGES 2,111,095. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.